Exchange Traded Concepts LLC increased its holdings in shares of Welltower Inc. (NYSE:WELL - Free Report) by 92.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,709 shares of the real estate investment trust's stock after buying an additional 4,675 shares during the period. Exchange Traded Concepts LLC's holdings in Welltower were worth $1,493,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Wellington Management Group LLP raised its stake in shares of Welltower by 14.0% during the first quarter. Wellington Management Group LLP now owns 21,289,684 shares of the real estate investment trust's stock worth $3,261,792,000 after buying an additional 2,614,562 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Welltower by 41.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 8,923,852 shares of the real estate investment trust's stock valued at $1,367,226,000 after purchasing an additional 2,622,384 shares in the last quarter. Northern Trust Corp increased its stake in Welltower by 0.4% in the first quarter. Northern Trust Corp now owns 8,467,221 shares of the real estate investment trust's stock valued at $1,297,263,000 after purchasing an additional 36,725 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Welltower by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,164,840 shares of the real estate investment trust's stock valued at $1,250,935,000 after purchasing an additional 532,135 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Welltower by 14.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 6,956,594 shares of the real estate investment trust's stock valued at $1,065,820,000 after purchasing an additional 877,856 shares in the last quarter. 94.80% of the stock is owned by institutional investors.
Welltower Stock Performance
NYSE WELL opened at $165.53 on Monday. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.44. The firm's fifty day moving average price is $165.11 and its two-hundred day moving average price is $154.92. Welltower Inc. has a 1 year low of $122.34 and a 1 year high of $171.09. The firm has a market capitalization of $110.71 billion, a P/E ratio of 93.52, a price-to-earnings-growth ratio of 1.86 and a beta of 0.93.
Welltower (NYSE:WELL - Get Free Report) last posted its quarterly earnings results on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.06. Welltower had a net margin of 12.18% and a return on equity of 3.38%. The firm had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.49 billion. During the same period in the prior year, the firm posted $1.05 earnings per share. The company's quarterly revenue was up 39.6% compared to the same quarter last year. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. As a group, research analysts anticipate that Welltower Inc. will post 4.88 EPS for the current year.
Welltower Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, August 21st. Shareholders of record on Tuesday, August 12th were given a dividend of $0.74 per share. This represents a $2.96 annualized dividend and a yield of 1.8%. This is an increase from Welltower's previous quarterly dividend of $0.67. The ex-dividend date of this dividend was Tuesday, August 12th. Welltower's payout ratio is currently 167.23%.
Insider Transactions at Welltower
In other news, Director Andrew Gundlach purchased 20,000 shares of the company's stock in a transaction on Monday, June 30th. The shares were purchased at an average cost of $151.46 per share, with a total value of $3,029,200.00. Following the completion of the transaction, the director owned 20,000 shares of the company's stock, valued at $3,029,200. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.21% of the company's stock.
Analysts Set New Price Targets
Several brokerages have commented on WELL. Evercore ISI upped their target price on shares of Welltower from $175.00 to $183.00 and gave the company an "in-line" rating in a research note on Monday, September 15th. Raymond James Financial reaffirmed a "strong-buy" rating on shares of Welltower in a research note on Tuesday, September 2nd. UBS Group began coverage on shares of Welltower in a research note on Friday. They issued a "buy" rating and a $195.00 target price for the company. Wells Fargo & Company upped their target price on shares of Welltower from $175.00 to $185.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Finally, Scotiabank upped their target price on shares of Welltower from $172.00 to $181.00 and gave the company an "outperform" rating in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Welltower presently has an average rating of "Moderate Buy" and a consensus price target of $177.55.
Read Our Latest Report on Welltower
Welltower Company Profile
(
Free Report)
Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.